Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph R Woska

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Current Protocols in Pharmacology|February 2, 2012
Overview of approaches to the identification of inhibitors of cytokine actionJoseph R Woska, Jeanne Magram
Journal of Cellular and Molecular Medicine|September 2, 2011
SNARE complex-mediated degranulation in mast cellsJoseph R Woska, Marc E Gillespie
Biochemical Pharmacology|May 8, 2007
The determination and correlation of molecular and cellular equilibrium Kd and kinetic k(off) values for small molecule allosteric antagonists of LFA-1Gary O Caviness, Mark E Labadia, Patricia A Giblin, et al.
Bioorganic & Medicinal Chemistry Letters|October 22, 2008
2-Aminobenzimidazoles as potent ITK antagonists: trans-stilbene-like moieties targeting the kinase specificity pocketHo Yin Lo, Jörg Bentzien, Roman W Fleck, et al.
Toxicology and Applied Pharmacology|May 27, 2017
An impedance-based approach using human iPSC-derived cardiomyocytes significantly improves in vitro prediction of in vivo cardiotox liabilitiesBryan Koci, Gregory Luerman, Anika Duenbostell, et al.
The Journal of Biological Chemistry|August 14, 2015
Signal Transduction and Intracellular Trafficking by the Interleukin 36 ReceptorSiddhartha S Saha, Divyendu Singh, Ernest L Raymond, et al.
Biochemical Pharmacology|November 26, 2008
Inhibition of pro-inflammatory cytokine production by the dual p38/JNK2 inhibitor BIRB796 correlates with the inhibition of p38 signalingLore M Gruenbaum, Racheline Schwartz, Joseph R Woska, et al.
Journal of Immunological Methods|June 12, 2003
Small molecule LFA-1 antagonists compete with an anti-LFA-1 monoclonal antibody for binding to the CD11a I domain: development of a flow-cytometry-based receptor occupancy assayJoseph R Woska, Kathleen Last-Barney, Robert Rothlein, et al.
Mabs|May 10, 2019
Retrospective analysis of model-based predictivity of human pharmacokinetics for anti-IL-36R monoclonal antibody MAB92 using a rat anti-mouse IL-36R monoclonal antibody and RNA expression data (FANTOM5)Jennifer Ahlberg, Craig Giragossian, Hua Li, et al.
Mabs|July 21, 2017
Generation and functional characterization of anti-human and anti-mouse IL-36R antagonist monoclonal antibodiesRajkumar Ganesan, Ernest L Raymond, Detlev Mennerich, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Current Protocols in Pharmacology|February 2, 2012
Overview of approaches to the identification of inhibitors of cytokine actionJoseph R Woska, Jeanne Magram
Journal of Cellular and Molecular Medicine|September 2, 2011
SNARE complex-mediated degranulation in mast cellsJoseph R Woska, Marc E Gillespie
Biochemical Pharmacology|May 8, 2007
The determination and correlation of molecular and cellular equilibrium Kd and kinetic k(off) values for small molecule allosteric antagonists of LFA-1Gary O Caviness, Mark E Labadia, Patricia A Giblin, et al.
Bioorganic & Medicinal Chemistry Letters|October 22, 2008
2-Aminobenzimidazoles as potent ITK antagonists: trans-stilbene-like moieties targeting the kinase specificity pocketHo Yin Lo, Jörg Bentzien, Roman W Fleck, et al.
Toxicology and Applied Pharmacology|May 27, 2017
An impedance-based approach using human iPSC-derived cardiomyocytes significantly improves in vitro prediction of in vivo cardiotox liabilitiesBryan Koci, Gregory Luerman, Anika Duenbostell, et al.
The Journal of Biological Chemistry|August 14, 2015
Signal Transduction and Intracellular Trafficking by the Interleukin 36 ReceptorSiddhartha S Saha, Divyendu Singh, Ernest L Raymond, et al.
Biochemical Pharmacology|November 26, 2008
Inhibition of pro-inflammatory cytokine production by the dual p38/JNK2 inhibitor BIRB796 correlates with the inhibition of p38 signalingLore M Gruenbaum, Racheline Schwartz, Joseph R Woska, et al.
Journal of Immunological Methods|June 12, 2003
Small molecule LFA-1 antagonists compete with an anti-LFA-1 monoclonal antibody for binding to the CD11a I domain: development of a flow-cytometry-based receptor occupancy assayJoseph R Woska, Kathleen Last-Barney, Robert Rothlein, et al.
Mabs|May 10, 2019
Retrospective analysis of model-based predictivity of human pharmacokinetics for anti-IL-36R monoclonal antibody MAB92 using a rat anti-mouse IL-36R monoclonal antibody and RNA expression data (FANTOM5)Jennifer Ahlberg, Craig Giragossian, Hua Li, et al.
Mabs|July 21, 2017
Generation and functional characterization of anti-human and anti-mouse IL-36R antagonist monoclonal antibodiesRajkumar Ganesan, Ernest L Raymond, Detlev Mennerich, et al.
Pageof 2